BRG1 may be increased during melanoma progression [101,146], potentially causing a shift of MITF target genes towards anti-apoptotic signaling via BIRC7/ML-IAP, although conflicting reports exist about BRG1 expression in melanoma progression [147]. Here, SMARCA4 is linked to melanoma.